London-based Aeva Health Secures £101k in Early-Stage Funding to Advance AI-Powered Women's Health Platform

Aeva Health Ltd, a London-based digital health innovator focused on women's chronic illnesses, has successfully secured £101k in a recent funding round. The investment, filed on 26 April 2026 with an allotment date on the same day, values the company at an estimated £1.6m post-money. This early-stage capital injection positions Aeva Health to further develop its AI-powered platform designed to provide integrated and personalised care for women.

Founded on 2 February 2024, Aeva Health addresses a critical gap in healthcare by offering a digital health solution for women managing chronic conditions such as thyroid disorders, Polycystic Ovary Syndrome (PCOS), endometriosis, and Irritable Bowel Syndrome (IBS). The company's proprietary "Six Pillars" framework leverages pattern recognition and predictive analytics to connect data across gut health, stress, sleep, movement, mental wellbeing, hormones, and the menstrual cycle. By integrating wearables, symptoms, test results, and health history, Aeva Health aims to reveal root causes rather than merely treating symptoms, acting as a 24/7 AI health companion that learns individual patterns and adapts care plans accordingly. The platform also provides access to vetted expert practitioners, aiming to end the "exhausting cycle of repeating your story to disconnected specialists." A mobile app is slated for release in mid-2026, with a founding membership currently open. The company, headquartered in London, currently employs six individuals.

This £101k funding round, with a post-money valuation of £1.6m, represents an early commitment to Aeva Health's vision. While specific financial metrics such as revenue or profit/loss are not publicly available for the nascent company, this initial funding underscores investor confidence in its potential.

The funding round for Aeva Health aligns with broader trends in the UK's health tech and FemTech sectors. The UK health tech market has seen significant investment, attracting over £2.8 billion since 2020, with London emerging as a leading hub for digital health innovation in Europe. This growth is propelled by increasing demand for digital health solutions and robust government support for healthcare innovation. Notably, the health tech sector experienced a 127% year-over-year increase in funding in 2023.

Aeva Health's focus on AI-powered solutions for women's health places it within two rapidly expanding segments. AI has become a dominant trend in early-stage funding, with over 60% of companies securing inaugural seed investments in 2025 explicitly leveraging AI. AI-powered diagnostics, in particular, are a leading funding category. Concurrently, the women's health market, often referred to as 'FemTech,' is gaining significant traction as a core investment theme in the UK. Women's health was among the top therapeutic areas for funding in 2023, attracting £66.2 million. The FemTech sector is experiencing a boom, with over £480 million in investment funding and an estimated annual growth rate of 30%. The UK government's renewed women's health strategy is also expected to stimulate further investment in the sector.

In terms of pre-seed funding, London continues to be a dominant ecosystem, accounting for 68% of all deals. While the average pre-seed round in the UK increased to £580k in 2024, up from £400k in 2022, and median pre-seed valuations averaged £3.2 million in Q1 2025, smaller rounds are also a common feature of the early-stage landscape. Indeed, nearly half (45%) of pre-seed rounds in Q3 2025 generated less than £200k, indicating that Aeva Health's raise fits within the typical range for very early-stage companies. The health tech and biotech sectors have shown resilience in seed valuations, with trends either flat or increasing, in contrast to declines observed in other industries.

Aeva Health's upcoming mobile app and founding membership program are key initiatives for the company as it seeks to establish its presence in the burgeoning digital women's health market. This initial funding round provides the necessary capital for Aeva Health to advance its mission of redefining chronic health management for women through innovative technology and expert support.